These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4960060)

  • 1. Studies of the mechanism whereby adjuvant disease is suppressed in rats pretreated with mycobacteria.
    Gery I; Waksman BH
    Int Arch Allergy Appl Immunol; 1967; 31(1):57-68. PubMed ID: 4960060
    [No Abstract]   [Full Text] [Related]  

  • 2. THE PATHOGENESIS OF ADJUVANT DISEASE IN THE RAT. I. A HISTOLOGIC STUDY OF EARLY LESIONS IN THE JOINTS AND SKIN.
    BURSTEIN NA; WAKSMAN BH
    Yale J Biol Med; 1964 Dec; 37(3):177-94. PubMed ID: 14235863
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvants and the reticuloendothelial system. The recall phenomenon of the stimulatory effects of adjuvants with homologous antigen.
    Aiyedun BA
    J Reticuloendothel Soc; 1972 Dec; 12(6):672-700. PubMed ID: 4197668
    [No Abstract]   [Full Text] [Related]  

  • 4. The adjuvant effect of a tubercle bacillary lipid on the antibody response of rabbits to sheep red cells.
    Pound AW; O'Rourke GE
    J Med Microbiol; 1971 Nov; 4(4):495-504. PubMed ID: 5002687
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of adjuvant-induced polyarthritis in the rat with special reference to associated immunological phenomena.
    Katz L; Piliero SJ
    Ann N Y Acad Sci; 1969 Oct; 147(14):517-36. PubMed ID: 4982914
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvanticity (immunity-inducing property) of cord factor in mice and rats.
    Saito R; Nagao S; Takamoto M; Sugiyama K; Tanaka A
    Infect Immun; 1977 Jun; 16(3):725-9. PubMed ID: 70404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression by procarbazine. I. Sites of action of the drug and effect on adjuvant arthritis and circulating antibody responses.
    Quagliata F; Phillips-Quagliata JM; Floersheim GL
    Cell Immunol; 1972 Feb; 3(2):198-212. PubMed ID: 4622095
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant arthritis in the rat. Effect of intraperitoneal injections of either whole dead mycobacteria or tuberculin.
    Currey HL
    Ann Rheum Dis; 1970 May; 29(3):314-20. PubMed ID: 4988297
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of the adjuvant effect of a tubercle bacillary lipid on the antibody response of rabbits to sheep erythrocytes.
    Pound AW; Donald KJ
    J Pathol; 1972 Sep; 108(1):59-71. PubMed ID: 4630791
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of the phagocytic activity of the reticuloendothelial system in adjuvant arthritis in the rat.
    Perllik F
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):138-42. PubMed ID: 134533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune mechanism in transplantation diseases in rats].
    Vischer TL; Stastny P; Ziff M
    Z Rheumaforsch; 1967 Apr; 26(3):107-13. PubMed ID: 4874656
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism.
    Beck FJ; Whitehouse MW
    Biochem Pharmacol; 1973 Oct; 22(19):2453-68. PubMed ID: 4147671
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli.
    Ben-Efraim S; Constantini-Sourojon M; Weiss DW
    Cell Immunol; 1973 Jun; 7(3):370-9. PubMed ID: 4198089
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of reticuloendothelial blockade on antibody formation and immunologic tolerance.
    Cruchaud A
    Lab Invest; 1968 Jul; 19(1):15-24. PubMed ID: 4174915
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Factors controlling the adjuvant or immunosuppressive action of antigens in complete Freund-type mixtures.
    White RG
    Ann Sclavo; 1971; 13(6):821-36. PubMed ID: 5005894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant activity of peptidoglyoans from mycobacteria].
    Adam A; Amar C; Ciorbaru R; Lederer E; Petit JF; Vilkas E
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(6):799-801. PubMed ID: 4211289
    [No Abstract]   [Full Text] [Related]  

  • 17. OBSERVATIONS ON BASOPHIL DEGRANULATION AS AN INDICATOR OF ANTIGEN-ANTIBODY REACTION.
    FRIEDLAENDER S; FRIEDLAENDER AS
    J Allergy; 1964; 35():361-70. PubMed ID: 14193189
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D.
    Koga T; Pearson CM
    J Immunol; 1973 Aug; 111(2):599-608. PubMed ID: 4197988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological reaction by wax D, a constituent of Mycobacterium tuberculosis].
    Tanaka A
    Kekkaku; 1972 Mar; 47(3):20-1. PubMed ID: 4113695
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant.
    Tanaka A
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.